ObsERV identifies patient-specific virus targets, so-called ERVs (endogenous retroviruses), expressed in cancer.
Evaxion has demonstrated that overexpression of such ERVs is strongly associated with the overall survival of cancer patients, notably of patients that are normally considered unrespon